Localisation of neurokinin 3 (NK3) receptor immunoreactivity in the rat gastrointestinal tract

被引:85
|
作者
Mann, PT
Southwell, BR
Ding, YQ
Shigemoto, R
Mizuno, N
Furness, JB
机构
[1] FOURTH MIL MED UNIV, DEPT ANAT, XIAN 710032, PEOPLES R CHINA
[2] KYOTO UNIV, FAC MED, DEPT MORPHOL BRAIN SCI, KYOTO 60601, JAPAN
基金
美国国家科学基金会; 英国医学研究理事会;
关键词
enteric nervous system; NK3; receptor; sensory neurons; co-localisation; NK1; calcium-binding proteins; nitric oxide synthase;
D O I
10.1007/s004410050846
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The localisation of the neurokinin 3 receptor (NK3r) in the rat gastrointestinal tract has been studied by using a polyclonal antiserum against the C-terminal portion (amino acids 388-452) of the rat NK3r. In the oesophagus, immunoreactivity for the NK3r was found on smooth muscle cells of the muscularis mucosae. NK3r immunoreactivity was not present on muscle cells of other regions. Nerve cell bodies immunoreactive for NK3r were seen in the myenteric and submucous plexuses of the small and large intestine, but not in the stomach or oesophagus. Immunoreactivity was largely confined to nerve cell surfaces. The reaction product was on the cell soma and initial parts of axons. Reactivity was not seen on nerve terminals. Immunoreactive nerve cells had Dogiel Type II morphology. Patterns of co-localisation of NK3r and immunoreactivity for other markers were examined in the ileum, to provide a basis from which to deduce the functional identity of NK3r-immunoreactive nerve cells. Most of the NK3r-immunoreactive nerve cells were also immunoreactive for the calcium-binding proteins, calretinin and calbindin, and all were immunoreactive for the NK1 receptor (NK1r). Nerve cells that were immunoreactive for nitric oxide synthase were not immunoreactive for either NK3r or NK1r. The projections of the calbindin and calretinin neurons were determined by nerve lesion studies. Their morphology, projections to the mucosa and other ganglia and immunoreactivity for the calcium-binding proteins suggest that the NK3r-immunoreactive neurons are intrinsic sensory neurons.
引用
收藏
页码:1 / 9
页数:9
相关论文
共 50 条
  • [41] Distribution of Fos-like immunoreactivity within the rat brain following intraventricular injection of the selective NK3 receptor agonist senktide
    Smith, ME
    Flynn, FW
    JOURNAL OF COMPARATIVE NEUROLOGY, 2000, 426 (03) : 413 - 428
  • [42] Localisation of tachykinin NK1 and NK3 receptors in the human prefrontal and visual cortex
    Tooney, PA
    Au, GG
    Chahl, LA
    NEUROSCIENCE LETTERS, 2000, 283 (03) : 185 - 188
  • [43] Central anti-hypertensive effect of tachykinin NK3 receptor antagonists in rat
    Lessard, A
    Laurin, M
    Yamaguchi, N
    Couture, R
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2004, 486 (01) : 75 - 83
  • [44] Permissive role of neurokinin NK3 receptors in NK1 receptor-mediated activation of the locus coeruleus revealed by SR 142801
    Bert, L
    Rodier, D
    Bougault, I
    Allouard, N
    Le-Fur, G
    Soubrié, P
    Steinberg, R
    SYNAPSE, 2002, 43 (01) : 62 - 69
  • [45] Evidence for NK3 receptor subtypes in rabbit isolated iris sphincter muscle using the NK3 receptor antagonists SR 142801 and SR 48968
    Medhurst, AD
    Hay, DWP
    Parsons, AA
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 117 : P203 - P203
  • [46] In vitro and in vivo characterization of NK3 receptors in the rabbit eye by use of selective non-peptide NK3 receptor antagonists
    Medhurst, AD
    Hay, DWP
    Parsons, AA
    Martin, LD
    Griswold, DE
    BRITISH JOURNAL OF PHARMACOLOGY, 1997, 122 (03) : 469 - 476
  • [47] Therapeutic Utility of NK3 Receptor Antagonists for the Treatment of Schizophrenia
    Dawson, Lee A.
    Smith, Paul W.
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (03) : 344 - 357
  • [48] Molecular and pharmacological characterization of the murine tachykinin NK3 receptor
    Sarau, HM
    Feild, JA
    Ames, RS
    Foley, JJ
    Nuthulaganti, P
    Schmidt, DB
    Buckley, PT
    Elshourbagy, NA
    Brawner, ME
    Luttmann, MA
    Giardina, GAM
    Hay, DWP
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 413 (2-3) : 143 - 150
  • [49] Opinion -: NK3 receptor antagonists:: the next generation of antipsychotics?
    Spooren, W
    Riemer, C
    Meltzer, H
    NATURE REVIEWS DRUG DISCOVERY, 2005, 4 (12) : 967 - 975
  • [50] New quinoline NK3 receptor antagonists with CNS activity
    Smith, Paul W.
    Wyman, Paul A.
    Lovell, Peter
    Goodacre, Caroline
    Serafinowska, Halina T.
    Vong, Antonio
    Harrington, Frank
    Flynn, Sean
    Bradley, Daniel M.
    Porter, Rod
    Coggon, Sara
    Murkitt, Graham
    Searle, Kirsten
    Thomas, David R.
    Watson, Jeannette M.
    Martin, William
    Wu, Zining
    Dawson, Lee A.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (03) : 837 - 840